Inventor
KOIZUMI NORIKO
JP24 patents
⚠️ This page may combine multiple inventors who share the name “KOIZUMI NORIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KYOTO PREFECTURAL PUBLIC UNIV CORP
9 patentsUS11918630B2Mar 5, 2024
Treatment of retina and nerve using laminin
KYOTO PREFECTURAL PUBLIC UNIV CORP0 citations62
US11730722B2Aug 22, 2023
Corneal endothelium ECM therapeutic medicaments
KYOTO PREFECTURAL PUBLIC UNIV CORP0 citations62
US11633477B2Apr 25, 2023
Treatment of cornea using laminin
KYOTO PREFECTURAL PUBLIC UNIV CORP0 citations62
US11382904B2Jul 12, 2022
Therapeutic drug for diseases related to endoplasmic reticulum cell death in corneal endothelium
KYOTO PREFECTURAL PUBLIC UNIV CORP1 citations62
US10959997B2Mar 30, 2021
Combined agent for cell therapy of corneal endothelial cell
KYOTO PREFECTURAL PUBLIC UNIV CORP0 citations62
US12072334B2Aug 27, 2024
Corneal endothelial cell marker
KYOTO PREFECTURAL PUBLIC UNIV CORP0 citations58
US10908161B2Feb 2, 2021
Corneal endothelial cell marker
KYOTO PREFECTURAL PUBLIC UNIV CORP0 citations58
US11624053B2Apr 11, 2023
Application of laminin to corneal endothelial cell culture
KYOTO PREFECTURAL PUBLIC UNIV CORP0 citations54
US9616101B2Apr 11, 2017
Differentiation marker and differentiation control of eye cell
KYOTO PREFECTURAL PUBLIC UNIV CORP0 citations48
THE DOSHISHA
8 patentsUS12343356B2Jul 1, 2025
mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof
THE DOSHISHA0 citations61
US11857544B2Jan 2, 2024
Composition or method including (t)ew-7197 for treating or preventing corneal endothelial diseases
THE DOSHISHA0 citations61
US11446263B2Sep 20, 2022
Caspase inhibitor-containing drug for treating or preventing disorders caused by TGF-β, and applications thereof
THE DOSHISHA0 citations61
US11445723B2Sep 20, 2022
Method and container for preserving corneal endothelial cells
THE DOSHISHA0 citations61
US11433090B2Sep 6, 2022
mTOR-inhibitor-containing medicine for treating or preventing ophthalmic symptoms, disorders, or diseases, and application thereof
THE DOSHISHA1 citations61
US10980787B2Apr 20, 2021
Drug for treating or preventing disorder caused by TGF-B signals, and application thereof
THE DOSHISHA0 citations61
US10813920B2Oct 27, 2020
Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage
THE DOSHISHA0 citations51
US11576914B2Feb 14, 2023
Drug for treating or preventing disorder caused by TGF-β signaling, and application thereof
THE DOSHISHA0 citations50